1 Wernig M, "c-Myc is dispensable for direct reprogramming of mouse fibroblasts" 2 : 10-12, 2008
2 Bug G, "Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells" 65 : 2537-2541, 2005
3 Yu IT, "Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation" 56 : 473-480, 2009
4 Jung GA, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway" 9 : 66-, 2008
5 Teng HF, "Valproic acid enhances Oct4 promoter activity in myogenic cells" 110 : 995-1004, 2010
6 Kuendgen A, "The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia" 106 : 112-119, 2006
7 Biernaskie J, "Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury" 27 : 9545-9559, 2007
8 McKenzie IA, "Skin derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system" 26 : 6651-6660, 2006
9 Qiu Z, "Skeletal myogenic potential of mouse skin-derived precursors" 19 : 259-268, 2010
10 Niwa H, "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells" 24 : 372-376, 2000
1 Wernig M, "c-Myc is dispensable for direct reprogramming of mouse fibroblasts" 2 : 10-12, 2008
2 Bug G, "Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells" 65 : 2537-2541, 2005
3 Yu IT, "Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation" 56 : 473-480, 2009
4 Jung GA, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway" 9 : 66-, 2008
5 Teng HF, "Valproic acid enhances Oct4 promoter activity in myogenic cells" 110 : 995-1004, 2010
6 Kuendgen A, "The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia" 106 : 112-119, 2006
7 Biernaskie J, "Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury" 27 : 9545-9559, 2007
8 McKenzie IA, "Skin derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system" 26 : 6651-6660, 2006
9 Qiu Z, "Skeletal myogenic potential of mouse skin-derived precursors" 19 : 259-268, 2010
10 Niwa H, "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells" 24 : 372-376, 2000
11 Kim JB, "Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors" 454 : 646-650, 2008
12 Perucca E, "Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience" 16 : 695-714, 2002
13 Li Y, "Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4" 105 : 635-637, 2005
14 Hunt DP, "Multipotent skin-derived precursors: from biology to clinical translation" 20 : 522-530, 2009
15 Fernandes KJ, "Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential" 363 : 185-198, 2008
16 Zhang P, "Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression" 285 : 9180-9189, 2010
17 Fernandes KJ, "Isolation, expansion, and differentiation of mouse skin-derived precursors" 482 : 159-170, 2009
18 Toma JG, "Isolation of multipotent adult stem cells from the dermis of mammalian skin" 3 : 778-784, 2001
19 Toma JG, "Isolation and characterization of multipotent skin-derived precursors from human skin" 23 : 727-737, 2005
20 Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors" 126 : 663-676, 2006
21 Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors" 131 : 861-872, 2007
22 Huangfu D, "Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds" 26 : 795-797, 2008
23 Yu J, "Induced pluripotent stem cell lines derived from human somatic cells" 318 : 1917-1920, 2007
24 Buranasinsup S, "In vitro osteogenesis from human skin-derived precursor cells" 48 : 263-269, 2006
25 Phiel CJ, "Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen" 276 : 36734-36741, 2001
26 Hsieh J, "Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells" 101 : 16659-16664, 2004
27 Nakagawa M, "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts" 26 : 101-106, 2008
28 Loh YH, "Generation of induced pluripotent stem cells from human blood" 113 : 5476-5479, 2009
29 Okita K, "Generation of germline-competent induced pluripotent stem cells" 448 : 313-317, 2007
30 Nichols J, "Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4" 95 : 379-391, 1998
31 Sun N, "Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells" 106 : 15720-15725, 2009
32 Hanna J, "Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency" 133 : 250-264, 2008
33 Kim JB, "Direct reprogramming of human neural stem cells by OCT4" 461 : 643-649, 2009
34 Eminli S, "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells" 41 : 968-976, 2009
35 Schuh R, "A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene" 47 : 1025-1032, 1986
36 Shi Y, "A combined chemical and genetic approach for the generation of induced pluripotent stem cells" 2 : 525-528, 2008